Aerobic Exercise: Clinical Trials

9 trials of Aerobic Exercise, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting, 1 terminated. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Unknown 2, Recruiting 1, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Aerobic Exercise: new trials by email Literature Review of Aerobic Exercise trials Research Report on Aerobic Exercise

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Aerobic Exercise, Counseling, Nicotine patch - Nicotine Dependence
Phase 3RecruitingJasper A. Smits3602023-12-272026-05-15
The Acute Effects of Exercise and Caffeine on Working Memory During Acute Caffeine Deprivation
Acute Exercise, Caffeine Powder - Acute Exercise, Caffeine Withdrawal
Phase 2 / Phase 3CompletedWestern University, Canada72022-01-102024-03-04
Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients(EXCAVATION-CHN1)
Aerobic Exercise, Health Education - Primary Hypertension
Phase 3UnknownFirst Affiliated Hospital, Sun Yat-Sen University402016-05-012017-04-25
Effect of Physical Exercise in Alzheimer Patients
Aerobic exercise - Alzheimer Disease
Phase 3CompletedCopenhagen University Hospital, Rigshospitalet2002012-01-012014-12-02
Impact of Aerobic Exercise on Asthma Morbidity
Aerobic exercise, Usual care - Asthma
Phase 3CompletedCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal662010-01-012018-02-12
Smoking Termination Enhancement Project (STEP)
Cognitive Behavioral Treatment, Nicotine Patch, Wellness Program - Smoking
Phase 3CompletedSouthern Methodist University1502009-09-012016-02-04
Exercise During Chemotherapy for Patients With Hematological Malignancies
Aerobic exercise, Fatigue counseling - Hematological Diseases, Hematological Malignancies
Phase 3UnknownCharite University, Berlin, Germany602009-05-012009-12-23
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston11262004-01-012019-11-29
Exercise and Behavioral Therapy Trial (EBT).
Aerobic exercise, Cognitive behavioral therapy - Persian Gulf Syndrome
Phase 3CompletedUS Department of Veterans Affairs10641999-03-012015-06-26

Conditions studied

Motor Activity (3)  ·  Alzheimer Disease (1)  ·  Asthma (1)  ·  Burns (1)  ·  Essential Hypertension (1)  ·  Fatigue (1)  ·  Hematologic Diseases (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Inflammation (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Memory Disorders (1)  ·  Multiple Myeloma (1)  ·  Persian Gulf Syndrome (1)

Sponsors

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (1)  ·  Charite University, Berlin, Germany (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Jasper A. Smits (1)  ·  Southern Methodist University (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  US Department of Veterans Affairs (1)  ·  Western University, Canada (1)

Countries

United States (4)  ·  Canada (2)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Puerto Rico (1)

Top investigators

Jasper Smits, PhD (2)  ·  David N Herndon, MD (1)  ·  Fernando Dimeo, MD (1)  ·  Haipeng Xiao, PhD (1)  ·  Harry Prapavessis, PhD (1)  ·  Michael Zvolensky, PhD (1)  ·  Simon L Bacon, PhD (1)  ·  Steen G Hasselbalch, Professor (1)

Results publications

PMID 19734776, PMID 20881067, PMID 22463890, PMID 22606232, PMID 22895351, PMID 23148822, PMID 23150682, PMID 23303450, PMID 23794569, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 26513517, PMID 27171844, PMID 27433905, PMID 28240622, PMID 28615271, PMID 30319397, PMID 31718666, PMID 33246408, PMID 35249488, PMID 36761410, PMID 37730689

NIH funding

P50GM060338 (1), R01CA273221 (1), R01DA027533 (1)